Table 3 Serum sMICA levels relative to hepatic cancer staging
| Â | Tumor grading | Case subgroups | sMICA (pg/ml) | P (relative to T1) |
|---|---|---|---|---|
TNM staging | T1 | 4.3% (6) | 389.6 ± 153.3 |  |
T2 | 23.4% (33) | 712.3 ± 108.6 | <0.0001 | |
T3 | 59.5% (84) | 883.7 ± 133.2 | <0.0001 | |
T4 | 12.8% (18) | 699.1 ± 212.5 | <0.0001 | |
Pathological Differentiation | high | 56.1% (79) | 718.9 ± 113.6 | >0.05 |
Intermediate | 33.3% (47) | 753.5 ± 132.1 | >0.05 | |
low | 10.6% (15) | 840.8 ± 232.2 | >0.05 |